Result description
Antimicrobial coating activity
Our coatings display antimicrobial activity against bacteria, fungi and viruses. During this project, successful tests were made against E. coli, S. aureus and H1N1. We have also recently received preliminary positive tests against SARS-CoV-2, which we will update soon.
Effectiveness of the filters
By combining our membranes with the antimicrobial coating, we have developed filters that are ideal candidates for use in Air and Water Purification. Those filters have been tested for their resistance to airflow, their dust entrapment capabilities and antimicrobial efficiency in air. The resistance to airflow was proved to be higher than that of similarly-sized HEPA filters (24 m3/h at 200 Pa). The dust entrapment tests showed that the efficiency of our filters was on average above 90% for particle sizes above 4 μm and above 50% for particles between 0.4 and 4 μm. It was also found that our technology, with the active coating, can reduce the concentrations of bacteria and viruses in air by more than 99.999% in a single-pass (results conducted with H1N1 – which caused the Spanish Flu Pandemic in 1918 and the Swine Flu Epidemic in 2009 and S. aureus).
Addressing target audiences and expressing needs
- To raise awareness and possibly influence policy
- Grants and Subsidies
- Loans
- Other blended financing
- Business partners – SMEs, Entrepreneurs, Large Corporations
- Investor introductions
- Business plan development
- Use of research Infrastructure
- Collaboration
- Business Angels
- Venture Capital
- Crowd-funding Equity
- Other type of Investment
With adequate emergency finance, we can go to market within 2 months. This would include coating these products with our antiviral technology: ceramic air filters (to be used in air cleansers and respirators), face masks, rapid-deployment self-adhesive stickers or films and gloves. To quickly achieve this aim, we are raising €4m for phase 1 in developing a proof of concept of these coated products, including manufacturing-readiness through our lined-up partners. Upon a successful Phase 1, a follow-on Phase 2 (Deployment / Widespread) would require €30m to rapidly deploy this technology
- Public or private funding institutions
- EU and Member State Policy-makers
- International Organisations (ex. OECD, FAO, UN, etc.)
- Other Actors who can help us fulfil our market potential
- Research and Technology Organisations
- Academia/ Universities
- Private Investors
R&D, Technology and Innovation aspects
Demonstrated scale-up to a production rate of 3,000 filter elements per day (TRL6). Lined up a range of manufacturers to help in the current emergency situation to be able to more quickly deploy our solution in the fight against COVDI-19. The different anti-SARS-CoV-2 product concepts are currently at TRL3/4. An emergency funding is now required to run the necessary safety and efficacy tests.
Result submitted to Horizon Results Platform by SMART SEPARATIONS LTD
Please 
Get instant access to tailored funding opportunities that perfectly match your needs. This powerful feature is exclusively available to our premium members—helping you save time, stay ahead of the competition, and secure the right funding faster.
Curious about who’s viewing your listings? Unlock insights into your last 20 visitors and discover potential leads instantly! 